Simplex Trading
EVGN icon

Simplex Trading’s Evogene EVGN Stock Holding History

Simplex Trading’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-500
Closed -$4K – 9113
2023
Q4 		$4K Buy
+500
New +$3.15K ﹤0.01% 7958
2022
Q2 		– Sell
-700
Closed -$9K – 10229
2022
Q1 		$9K Sell
700
-2,110
-75% -$28.5K ﹤0.01% 8951
2021
Q4 		$46K Buy
2,810
+890
+46% +$20.2K ﹤0.01% 7364
2021
Q3 		$64K Hold
1,920
– – ﹤0.01% 7214
2021
Q2 		$65K Buy
1,920
+1,902
+10,567% +$74.5K ﹤0.01% 7305
2021
Q1 		$91K Buy
+18
New +$1.11K ﹤0.01% 5882

Other funds holding EVGN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RIG
Renaissance Investment Group Lenox, Massachusetts $508M AUM 30.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Simplex Trading's EVGN Position: Q3 2024 in Review

Simplex Trading sold out of Evogene (EVGN) in Q3 2024, closing a stake of 117 shares.

Simplex Trading first reported a position in EVGN in Q1 2021 and held it in 13 quarters. The position peaked at $92K in Q1 2021. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

  • Simplex Trading reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 117 Evogene shares in Q3 2024.
  • Simplex Trading first reported a position in Evogene in Q1 2021 and held it in 13 quarters.
  • Simplex Trading's Evogene position peaked at $92K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.